John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 4,109 shares at $3.40 ($14K) on 2021-04-01, disclosed to the SEC on 2021-04-01.
Open-market sale of $14k AKBA by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |